BIOLINERX LTD-SPONS ADR (BLRX)

US09071M2052 - ADR

0.3233 -0.22 (-40.7%)

After market: 0.325 +0 (+0.53%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates

		2021	2022	2023
Revenue YoY % growth				4.8M
EBITDA YoY % growth		-24.074M -9.46%	-28.503M -18.40%	-41.607M -45.97%
EBIT YoY % growth		-24.777M -8.07%	-29.157M -17.68%	-42.991M -47.45%
Operating Margin		N/A	N/A	-895.65%
EPS YoY % growth		N/A	N/A	N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


EPS Q2Q % growth
Revenue Q2Q % growth
EBITDA Q2Q % growth
EBIT Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)

Period	Reported	Estimate	Difference	Surprise
Q3 2023 Q2Q % growth	-4.08 -133.79%			%
Q1 2023 Q2Q % growth
Q4 2022 Q2Q % growth
Q3 2022 Q2Q % growth
Q2 2022 Q2Q % growth
Q1 2022 Q2Q % growth
Q4 2021 Q2Q % growth
Q3 2021 Q2Q % growth
Q2 2021 Q2Q % growth
Q1 2021 Q2Q % growth
Q4 2020 Q2Q % growth
Q3 2020 Q2Q % growth
Q2 2020 Q2Q % growth
Q1 2020 Q2Q % growth
Q4 2019 Q2Q % growth
Q3 2019 Q2Q % growth
Q2 2019 Q2Q % growth
Q1 2019 Q2Q % growth
Q4 2018 Q2Q % growth
Q3 2018 Q2Q % growth
Q2 2018 Q2Q % growth
Q1 2018 Q2Q % growth

Recent Revenue VS Estimates Surprises (USD)

Period	Reported	Estimate	Difference	Surprise
Q1 2023 Q2Q % growth
Q4 2022 Q2Q % growth
Q3 2022 Q2Q % growth
Q2 2022 Q2Q % growth
Q1 2022 Q2Q % growth
Q4 2021 Q2Q % growth
Q3 2021 Q2Q % growth
Q2 2021 Q2Q % growth
Q1 2021 Q2Q % growth
Q4 2020 Q2Q % growth
Q3 2020 Q2Q % growth
Q2 2020 Q2Q % growth
Q1 2020 Q2Q % growth
Q4 2019 Q2Q % growth
Q3 2019 Q2Q % growth
Q2 2019 Q2Q % growth
Q1 2019 Q2Q % growth
Q4 2018 Q2Q % growth
Q3 2018 Q2Q % growth
Q2 2018 Q2Q % growth
Q1 2018 Q2Q % growth

EPS and Revenue Revisions

	Next Q (1 month)	Next Q (3 month)	Next Year (1 month)	Next Year (3 month)
EPS	N/A	N/A	N/A	N/A
Revenue	N/A	N/A	N/A	N/A